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ABSTRACT [571 
A bio-reactor system where cell growth microcarrier 
beads are suspended in a zero head space fluid medium 
by rotation about a horizontal axis and where the fluid 
is continuously oxygenated from a tubular membrane 
which rotates on a shaft together with rotation of the 
culture vessel. The oxygen is continuously throughput 
through the membrane and disbursed into the fluid 
medium along the length of the membrane. 
97-101. 
4 Claims, 2 Drawing Sheets 
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METHOD FOR CULTURING MAMMALIAN 
CELLS IN A HORIZONTALLY ROTATED 
BIOREACTOR 
ORIGIN OF THE INVENTION 
The invention described herein was made in the per- 
formance of work under a NASA contract and is sub- 
ject to provisions of Section 305 of the National Aero- 
nautics and Space Act of 1958, Public Law 85-568 (72 
Stat. 435, 42 U.S.C. 2457). 
RELATED APPLICATIONS 
This is a division of application Ser. No. 07/213,558, 
filed Jun. 30, 1988, now U.S. Pat. No. 5,026,650. 
This application has subject matter related to the 
subject matter disclosed in commonly owned U.S. pa- 
tent applications Ser. No. 087,358, filed Aug. 20, 1987, 
now U.S. Pat. No. 4,839,046 and Ser. No. 07/213,559, 
filed Jun. 30, 1988, now U.S. Pat. No. 4,988,623. 
FIELD OF T H E  INVENTION 
The present invention relates to an improved bioreac- 
tor vessel system useful for carrying out cell and tissue 
culture. 
BACKGROUND OF T H E  INVENTION 
Bacterial cell culture processes have been developed 
for the growth of single cell bacteria, yeast and molds 
which can be characterized as encased with a tough cell 
wall. Mammalian cell culture, however. is much more 
complex because such cells are more delicate and have 
a more complex nutrient requirement for development. 
Large scale culture of bacterial type cells is highly de- 
veloped and such culture techniques are less demanding 
and are not as difficult to  cultivate as mammalian cells. 
Bacterial cells can be grown in large volumes of liquid 
medium and can be vigorously agitated without any 
significant damage. Mammalian cells, on the other 
hand, cannot withstand excessive turbulent action with- 
out damage to the cells and must be provided with a 
complex nutrient medium to support growth. 
In addition, mammalian cells can have a special re- 
quirement because most animal cells must attach them- 
selves to some surface in order to duplicate. On a small 
scale, mammalian cells have been grown in containers 
with small wells or pores to provide surface anchors for 
the cells. However. the cell culture for mammalian cells 
in a container with microwells generally does not pro- 
vide sufficient surface area to grow mammalian cells on 
a large scale basis. Also horizontal roller bottles which 
are partially filled with nutrient media and in which 
cells either attach or distributed through the media are 
used for cell culture. However they are inefficient from 
a volume perspective and induce shear inhibiting three 
dimensional growth of delicate tissue. To provide 
greater surface areas, microcarrier beads have been 
developed for providing surface areas for the cultured 
cells to attach. However, microcarrier beads with at- 
Small bio-reactor vessels with internal moving parts 
may damage mammalian cells and also subject the cells 
to high fluid shearing stresses. If the microcarrier beads 
collide with one other in the suspension, the attached 
5 culture cells can be damaged. 
In summary, bio-reactors used to  culture mammalian 
cells typically utilize mechanical parts, air o r  fluid 
movement as a lift mechanism to achieve particle sus- 
pension. Such mechanisms induce damage to growing 
10 cells or tissues either directly or indirectly by fluid 
shear. 
PRIOR A R T  
Prior art which is known to applicant include the 
Paper entitled, “The Clinostat-A Tool For  Analyz- 
ing The Influence Of Acceleration On Solid-Liquid 
Systems” by W. Briegleb, published by the proceedings 
of a workshop on Space Biology, Cologne Germany, on 
20 Mar. 11, 1983 (ESASP-206, May 1983). In this paper, 
clinostat principals are described and analyzed relative 
to gravity affects. Some clinostat experiments are de- 
scribed including experiments where cultures are 
grown within cylinders which are rotated about a hori- 
Paper entitled, “Particle Orbits In A Rotating Liq- 
uid’’, by William W. Fowlis and Dale M. Kornfeld, a 
Nasa white paper planned for publication. The Nasa 
paper discloses use of latex microspheres up to 3 mi- 
30 crometers in diameter in a rotating reactor cylinder 
where the cylinder is rotated about a horizontal axis to 
keep the particles in suspension. The rotation of the 
reactor cylinder maintains the particles in suspension 
without agitation to cause particle collision which 
U.S. Pat. No. 3,676,074 relates to an apparatus for 
treating organic waste where a cylinder is rotated about 
a stationary horizontal pipe which has a central air input 
for supplying an air input to the waste material. 
US. Pat. No. 4,537,860 which relates to a static or  
stationary system for cell culture of animal cells where 
the cells in the vessel are supplied with a nutrient 21 
which passes through a porous tube 19 into the matrix 
(with cells) and that exits through passages 24 and 25. 
U.S. Pat. No. 4,310,630 relates to a stationary or  static 
cell culture growth device. In the ’630 patent, the paten- 
tee proposes to have a rotating cylinder about a hori- 
zontal axis which is rotatable between 5 and 20 RPM. 
50 Included within the vessel is a matrix of tubular ele- 
ments 11 for providing increased surface area for 
growth of cells. Not all of the elements 11 are covered 
with nutrient and the gas is supplied through one inlet 
and exited through an outlet. 
In U.S. Pat. No. 4,605,626, an electrode assembly 16 
is rotated about a vertical axis and inert gas is passed 
through a gas sparger 26 for dispersal as bubbles into a 
bacteria solution 14. The shaft rotates and agitates while 
the chamber remains static. 
U.S. Pat. No. 4,264,739 relates to  a suarger for a mass 
15 following: 
25 zontal axis. 
35 would result in flocculation. 
40 
45 Oxygen is passed through a permeable membrane 25. 
55 
60 
tached culture cells require means for suspension in a cell culture system which is comprised o f a n  elongated 
bio-reactor vessel to  provide suspension of the cells and tube having a plurality of ports. 
fresh nutrients. To obtain suspension, such bio-reactor U.S. Pat. No. 4,343,904 relates to  growth of animal 
vessels have used internal propellers or movable me- cells and a vertical cylindrical vessel having spaced 
chanical agitation devices which are motor driven so 65 apart plates on an axial shaft. An external pumping loop 
that the moving parts within a vessel cause agitation in is provided for circulating the contents of the vessel 
the fluid medium for the suspension of mammalian cells from the bottom to the top of the vessel. Cell growth is 
carried on microcarrier beads. carried out by substantially filling the vessel with cells 
3 
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and growth medium and allowing the cells to settle onto The system thus involves rotating a fluid nutrient 
disk surfaces and rotating the shaft while circulating the medium having zero head space having a first density 
vessel contents from the bottom to the top for mixing. about a nearly rotational horizontal axis where discrete 
U.S. Pat. No. 4,649,117 discloses an air lift bioreactor suspension materials disposed in the fluid medium have 
for maintaining cells in suspension and includes a cen- 5 a same or different density from the density of the fluid 
trally located gas inlet means at the lower end of the nutrient medium. The rotation of the fluid nutrient me- 
mixing chamber, a conical side wall in the growth dium is controlled to place the discrete suspension mate- 
chamber and introducing an oxygen containing gas to rials in suspension at spatial locations in the fluid nutri- 
bubble up through the cells and liquid medium to carry ent medium out of an interference relationship with one 
the cells and liquid medium upward from the mixing 10 another by virtue of the rotation and so that they are not 
chamber to the growth chamber and so that the cells subjected to  fluid shear forces generated by velocity 
and liquid medium flow downwardly along the conical gradients at the boundary layer at the vessel wall. While 
side wall to replace the cells and liquid medium being rotating the fluid nutrient a medium gas is allowed to 
carried upwards in the mixing chamber. The system is exchange across a diffusion membrane to the fluid nutri- 
for agitating the cells while minimizing shear forces. 
A paper entitled, “The Large Scale Cultivation of The unique design of this cell and tissue culture de- 
Mammalian Cells”, by Joseph Feder and William R. vice was initially driven by two requirements imposed 
Tolbert, published in the Scientific American Maga- by its intended use for feasibility studies for three di- 
zine, January 1983, Vol. 248, No. 1. pps. 36-43. In this mensional culture of living cells and tissues in space by 
paper, agitation of the cells is described as required to 20 NASA. These were 1) compatability with microgravity 
keep the cells suspended in the medium and describes a and 2) simulation of microgravity in one G. The vessels 
turbine agitator, a marine propeller agitator, and a vibro are designed to approximate the extremely quiescent 
mixer for mixing. The paper also describes a perfusion low shear environment obtainable in space where it 
reactor in which an agitation is provided by four slowly would be unnecessary for a lifting mechanism to oppose 
rotating flexible sheets of monofilament nylon which 25 particle sedimentation. Thus gentle culture environ- 
are rotated about a vertical axis while the medium in the ment was hypothesized to allow cells to achieve and 
main vessel is continuously pumped to the satellite filter maintain a three dimensional orientation, according to 
vessel. The filter retains the cells which are pumped cellular derived forces, and thus form higher order 
along with the remainder medium back into the vessel tissue structures. The rotating wall culture vessels, with 
for further proliferation. 30 associated features herein disclosed, developed for these 
A paper entitled, “Gravinsensitivity Of The Acellu- purposes were found to allow living cell cultures which 
lar, Slime, Mold, Physarum, Polycephalum Demon- exhibited the hypothesized features. It is observed that 
strated On The Fast Rotating Clinostat”, by Ingrid the rotating fluid effectively counters sedimentation and 
Block and Wolfgang Brigleb, published in the Euro- that the rotating wall effectively reduces adverse fluid 
pean Journal of Cell Biology 41, pps. 44-50, 1986. This 35 velocity gradients through the boundary layer at the 
paper describes rotation of a culture vessel about a vessel wall. The combined effects allowed bulk cultures 
horizontal axis for the simulation of weightlessness. The to be maintained with three dimensional orientations 
DaDer is a studv relative to the eravitv influences in the free of disruDtive shear forces which would limit the 
I5 ent medium. 
. .  * *  
control systems of cells. viability of dilicate cell types (particularly mammalian) 
40 and would limit the assembly of cells into higher order 
structures. It is observed in the case of attachment de- SUMMARY OF THE PRESENT INVENTION 
In the present invention, a horizontally disposed cyl- pendent cultures maintained on microcarrier beads that 
inder with end caps defines a cell culture vessel which the hundreds or thousands of beads participate in the 
is rotatable about an approximate horizontal axis. One formation of large high order structures bound by cell 
of the end caps is attached to a motor drive for rotating 45 bridging. Along the center axis of the vessel, is placed 
the cylinder about its centerline horizontal axis. A cen- the gas exchange device to support cell respiration. Gas 
trally located, coaxial, internal cylindrical support shaft mixtures are exchanged with the external environment 
is attached to the end caps and supports an annular tube across a diffusion membrane attached to a cylindrical 
of gas permeable membrane. In one of the end caps is an support. It was apparent to  scientists utilizing this in- 
access passageway to access an oxygen containing gas 50 strumentation that it offered significant advantages for 
through the shaft to the interior of the annular mem- earth based cell and tissue culture in terms of efficient 
brane at one end of the membrane. At the other end cap utilization of vessel volume, logistics, and unique cul- 
is an exit passageway to exit the gas through the shaft ture capabilities (particularly for attachment dependent 
from the interior of the membrane at the other end of microcarrier cultures). Additional benefit is derived 
the membrane. The exit end cap also has separate con- 55 from the efficient utilization of the vessel volume for 
trolled access entry ports to the interior of the cell CUI- culture allowing improved logistics where cell o r  cell 
ture vessel for sampling, changing or adding fluid or  product production is concerned. 
BRIEF DESCRIPTION OF T H E  DRAWINGS cells. For processing of mammalian cells, the system is 
sterilized and fresh fluid medium, microcarrier beads, 60 FIG. 1 shows a perspective view of the general orga- 
and cells are admitted to completely fill the cell culture nization of the present invention. 
vessel. An oxygen containing gas is admitted to  the FIG. 2 shows a view in partial cross section through 
interior of the permeable membrane which prevents air a horizontally rotated cell culture vessel illustrating an 
bubbles from being introduced into the medium. The application of the present invention. 
cylinder is rotated at a low speed within an incubator so 65 FIG. 3 is a view in cross section taken along line 3-3 
that the circular motion of the fluid medium uniformly of FIG. 2; and 
suspends the microbeads throughout the cylinder dur- FIG. 4 is a view in cross section taken along line 4 - 4  
ing the cell growth period. of FIG. 2. 
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DESCRIPTION O F  T H E  PREFERRED 
EMBODIMENT 
Referring now to FIG. 1, the general organization of 
the present invention is illustrated. A frame means 10 
has vertical and spaced apart plates 11, 12 which sup- 
port a motor pulley 14 and a housing pulley 13 where 
the pulleys 13, 14 are connected by a belt drive 15. The 
motor pulley 14 is coupled to a motor 16 which can be 
controlled in a well known manner to  provide a desired 
drive speed. 
The housing pulley 13 is connected to a drive shaft 17 
which extends through a rotative coupling 18 to an inlet 
end cap 20. The inlet end cap 20 is attached to a central 
assembly 21 and to a tubular outer culture cylinder 22. 
At the other end of the central assembly 21 and the 
culture cylinder 22 is an outlet end cap 24. 
An air pump 25 on the frame means 10 is connected 
by input tubing 26 to a filter 27. An output tubing 28 
from the pump 25 couples to the rotative coupling 18 
where the air input is coupled from a stationary annular 
collar to an internal passageway in the rotating drive 
shaft 17. 
Referring now to FIG. 2, the cell culture system of 
the present invention is illustrated in partial cross sec- 
tion where the rotative coupling 18 receives the output 
tubing 28 and the drive shaft 17 has a central air inlet 
passageway 30 for the passage of air. The drive shaft 17 
is attached to a coupling shaft 17a which extends 
through a central opening 31 in the inlet end cap 20. 
The coupling shaft 17a is threadedly attached to a cylin- 
drically shaped, central support member 32. The central 
passageway 30 extends inwardly through the shafts 17, 
17a to a transverse opening 33 which couples the air 
inlet passageway 30 to the exterior surface 35 of the 
central support member 32. The central support mem- 
ber 32 is sealingly received in a counterbore in the inlet 
end cap 20 and at its opposite end. the support member 
32 is sealingly received in a counterbore of the outlet 
end cap 24. A tubular outlet member 3% is threadedly 
attached through a bore in the outlet end cap 24 to a 
blind bore in the support member 32 and an air exit 
passageway 36 in the outlet coupling is connected by a 
transverse opening 37 to the exterior surface 35 of the 
central support member 32. A tubular oxygen permea- 
ble membrane 40 is disposed over the central support 
member 32 and has its ends extending over the openings 
33 and 37 in the central support member 32 so that the 
membrane 40 can be sealingly attached to the central 
support member 32 by O-rings or the like. Thus an air 
passageway is provided for an input of air through the 
passageway 30 and the transverse opening 33, through 
the annular space between the inner wall of the mem- 
brane 40 and the outer wall of the central support mem- 
ber 32 to  the exit transverse opening 37 and to the exit 
passageway 36. The membrane 40 may be made of sili- 
cone rubber which operates under air pressure to permit 
oxygen to  permeate through the wall of the membrane 
into the annulus of fluid medium surrounding the mem- 
brane and carbon dioxide to  diffuse in the opposite 
direction. 
Coaxially disposed about the central support shaft 32 
is a tubular outer cylinder 22 which can be glass. The 
cylinder 22 is sealing received on the end caps 20, 24 
and defines an annular culture chamber between the 
inner wall of the cylinder 22 and the outer surface of the 
membrane 40. On the inlet end cap 20 are circumferen- 
tially spaced apart cylindrical members 42. When the 
5 
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coupling shaft 17a is detached from the shaft 17, the 
members 42 provide a base for standing the cylinder 22 
upright or in a vertical position for sampling, changing 
or adding fluids to the system. 
In the outlet end cap 24, there are two or more access 
ports 44, 45, port 44 having closure means 46 and port 
45 being closed by valve 47. A hypodermic needle with 
fluid medium can be inserted through one access port to 
inject fluid when withdrawing fluid from the other port. 
In this regard samples or media can be withdrawn with- 
out forming an air space, thereby perserving the zero 
head space. 
The present invention thus involves the central cylin- 
drical core which is a source of oxygenation through 
the cylindrical membrane and the membrane and outer 
wall of the vessel are rotated about a horizontal axis. 
This involves a type of clinostat principal, i.e. a princi- 
pal that fluid rotated about a horizontal or nearly hori- 
zontal axis can effectively suspend particles in the fluid 
independent of the effects of gravity. The rotational 
speed of the cylinder 22 effectively eliminates the veloc- 
ity gradient at the boundary layer between the fluid and 
the cylinder wall. Thus, shear effects caused with a 
rotating fluid and stationary wall are significantly re- 
duced or eliminated. 
In an experimental use a high density culture of baby 
hamster kidney cells were produced by utilizing beads 
constructed from cytodex 3 material and utilizing a 
microcarrier medium prepared with low bicarbonate 
and 20 mM HEPES buffer, 10% fetal calf serum and 
antibiotics (PH 7.35+10 mlA NaOH (In) where the 
seeding density of the cells were 6 to 8 cells per bead 
and the bead density was 15 mg/ml. 
In the process the vessel was soaked in ethyl alcohol 
overnight, rinsed with Millipore quality water, 
wrapped and autoclaved. After cooling, the vessel was 
rinsed with complete medium prior to loading the 
beads. The beads were loaded into the vessel via the 
syringe barrel attached to one of the ports and the vessel 
was filled with medium and placed in an incubator and 
allowed to run for about 30 minutes to equilibrate while 
preparing the cells. The stored frozen cells were 
thawed, suspended in the medium, counted, diluted and 
loaded into the vessel via a syringe attached to one of 
the ports. The vessel was subsequently filled with cul- 
ture grown medium and rotation rate was set at 10 rpm. 
The air pump was actuated to move incubator air across 
the exchange membrane. Samples were withdrawn for 
cell counts at 1, 3 and 5 hours and approximately 24 
hours thereafter. 
The results of the tests were that the cells attach and 
grow on the beads at the high density of 15 mg/ml. The 
total cell counts at maximum cell number showed about 
1.1 X 109 cells at 168 hours. The attachment of cells to 
the beads occurred normally within the first hour. Fluid 
media change was made every 48 hours. 
Cell growth cultures have been successfully pro- 
duced by use of the present invention in development of 
human colon carcinoma cells, human embryonic kidney 
cells, tobacco callus cells, normal human embryonic 
kerotinocytes cells, normal human colon fibroblast 
cells, human promyleocytic leukemia cells, bovine em- 
bryonic kidney cells, normal embryonic lung cells, 
mouse melanoma cells, mouse hybridoma cells. As can 
be appreciated, the ability to grow mammialian cell 
cultures in a controlled environment is significant. 
The clinostatic principle involved is that a fluid rotat- 
ing (at the appropriate rate) about a horizontal or nearly 
7 
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horizontal axis (with respect to gravity) allows cells or 
cell attachment substrates having a density different 
from the fluid to travel in a nearly circular path and to 
deviate insignificantly from the fluid path. From the 
rotating reference frame the gravity vector is observed 5 including the steps of: 
closed in the drawings and specifications, but only as 
indicated in the appended claims. 
We claim: 
1. A method for growing mammalian cell cultures 
to rotate so that its time average Is nearly zero. This 
allows for suspension of the particles in a carrier me- 
dium with low fluid shear and with low interference. 
The vessel wall is rotated in order to reduce the adverse 
fluid velocity gradient through the boundary layer at 10 
this wall (which would occur at the interface between 
the moving fluid and fixed wall). The rotating wall is 
sufficient to cause fluid rotation due to viscosity. The 
operating limits are defined by the sedimentation rate of 
the particles in the fluid medium and the acceptable 15 
centrifugal force due to rotation. The present invention 
has excellent operating characteristics between 5 and 40 
RPM for culture of anchorage dependent cells on mi- 
crocarrier beads. It is possible to  vary the angular rota- 
tion rate in order to induce secondary flow patterns 20 
within the vessel, at the expense of transient fluid veloc- 
ity gradients at the wall boundary layers, useful for 
distributing nutrients or waste products. 
In the present invention the cell culture vessel is a 
cylinder rotated about a horizontal axis and the process 25 
utilizes’zero head space of fluid medium within the 
vessel. The entire cylindrical vessel is rotated to sus- 
pend the cells by rotation of the vessel so that suspen- 
sion of the cells is such that the beads are not agitated 
into contact with one another. At the same time the 30 
velocity gradient at the boundary layer of the fluid and 
the vessel wall is minimized. As a result of the horizon- 
tal orientation and clinostatic suspension of the parti- 
cles, less mixing force is required to move a particle 
from the bottom to the top of the vessel. The zero head 35 
space results in no air bubbles which cause disruption of 
fluid streamlines thus subiecting the culture to adverse 
providing a bibreactor comprising: an elongated tu- 
bular culture vessel; end caps enclosing the ends of 
said culture vessel; a shaft co-axially disposed in 
said culture vessel and extending between said end 
caps; and a tubular membrane disposed over said 
shaft between said end caps and sealed with respect 
to said shaft for defining an annular passageway 
between said membrane and said shaft and for de- 
fining an annular culture chamber between said 
membrane and the inner wall of said culture vessel, 
said membrane being oxygen permeable for ex- 
change of component gases with said culture 
chamber; 
completely filling said culture chamber with a fluid 
nutrient medium containing discrete suspension 
material and mammalian cells, said suspension ma- 
terial having a different density from the density of 
the fluid nutrient medium; 
rotating said culture vessel, said shaft and said mem- 
brane about the longitudinal axis of said culture 
vessel, said longitudinal axis being horizontally 
disposed; 
controlling the rotation of said culture vessel so as to 
place the discrete suspension materials and cells in 
suspension at spatial locations in the fluid nutrient 
medium out of interference relationship with one 
another by virtue of the rotation; and 
during said rotation, continuously introducing an 
oxygen containing gas under pressure at one end of 
said annular passage and exiting the gas at the other 
end of said annular passageway. 
2. The method as set forth in claim 1 wherein means 
shear effects. The centraigas exchange membrane per- 
mits a uniform dispersal of component gases from a 
central core to the fluid medium and reverse to allow 40 space. 
culture respiration. 
It will be apparent to those skilled in the art that 
various changes may be made in the invention without 
departing from the spirit and scope thereof and there- 
fore the invention is not limited by that which is en- 45 
are provided to recharge the medium at the same time a 
sample is withdrawn to prevent the formation of air 
3. The method as set forth in claim 1 wherein the 
4. The method as set forth in claim 1 wherein the 
method is carried out in unit gravity. 
method is carried out in less than unit gravity. * * * * *  
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